共 24 条
[1]
[Anonymous], 1993, Am J Hosp Pharm, V50, P305
[2]
Barber N., 1998, Clin Risk, V4, P103, DOI DOI 10.1177/135626229800400401
[3]
INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1995, 274 (01)
:29-34
[4]
The costs of adverse drug events in hospitalized patients
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1997, 277 (04)
:307-311
[6]
Adverse drug events in hospitalized patients - Excess length of stay, extra costs, and attributable mortality
[J].
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION,
1997, 277 (04)
:301-306
[7]
THE INCIDENT REPORTING SYSTEM DOES NOT DETECT ADVERSE DRUG EVENTS - A PROBLEM FOR QUALITY IMPROVEMENT
[J].
JOINT COMMISSION JOURNAL ON QUALITY IMPROVEMENT,
1995, 21 (10)
:541-548
[8]
Use of a standardized protocol to decrease medication errors and adverse events related to sliding scale insulin
[J].
QUALITY & SAFETY IN HEALTH CARE,
2006, 15 (02)
:89-91